SCHEMBL14770558

SCHEMBL14770558

c1ccc(-c2nc(-c3ccc4oc5ccc(-n6c7ccccc7c7ccccc76)cc5c4c3)cc(-n3c4ccccc4c4ccccc43)n2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.41
MAPK1 P28482 2/20 0.41
NPSR1 Q6W5P4 2/20 0.41
TSHR P16473 1/20 0.41
HSD17B10 Q99714 1/20 0.41
HPGD P15428 5/20 0.37
HTT P42858 1/20 0.35
KDM4E B2RXH2 5/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
ATM Q13315 1/20 0.35
ALDH1A1 P00352 5/20 0.34
TDP1 Q9NUW8 1/20 0.34
MEN1 O00255 4/20 0.33
KMT2A Q03164 4/20 0.33
PLA2G2A P14555 2/20 0.33
PLA2G4A P47712 2/20 0.33
PTPRF P10586 2/20 0.33
PTPN2 P17706 2/20 0.33
PTPN1 P18031 2/20 0.33
NTSR1 P30989 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26742511 0.99 MAPT (0.40) MAPTMAPK1NPSR1TSHRHSD17B10
SCHEMBL14770737 0.97 MAPT (0.41) MAPTMAPK1NPSR1TSHRHSD17B10
SCHEMBL14867934 0.96 MAPT (0.38) MAPTMAPK1NPSR1TSHRHSD17B10
SCHEMBL18842394 0.95 MAPT (0.41) MAPTMAPK1NPSR1TSHRHSD17B10
SCHEMBL14867962 0.92 MAPT (0.39) MAPTMAPK1NPSR1TSHRHSD17B10
SCHEMBL9890345 0.91 MAPT (0.39) MAPTMAPK1NPSR1TSHRHSD17B10
SCHEMBL9890099 0.90 KMT2A (0.40) MAPTMAPK1NPSR1TSHRHSD17B10
SCHEMBL14867924 0.90 KMT2A (0.40) MAPTMAPK1NPSR1TSHRHSD17B10
SCHEMBL14770738 0.89 KMT2A (0.40) MAPTMAPK1NPSR1TSHRHSD17B10
SCHEMBL15248710 0.89 KDM4E (0.41) MAPTTSHRHSD17B10HPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9604972-B2 Nitrogen-containing heteroaromatic ring compound IDEMITSU KOSAN CO., LTD. (JP) 2017-03-28 US disclosed
US-9604972-B2 Nitrogen-containing heteroaromatic ring compound IDEMITSU KOSAN CO., LTD. (JP) 2017-03-28 US disclosed
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2013-03-14 US disclosed
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2013-03-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND TDO2, AHR, NOC2L MAPT 2242/4885MAPK1 2836/4885NPSR1 1648/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.